Kerstin Valinder Strinnholm
Non-Executive Member
Haematology
Corline Biomedical AB
Sweden
Biography
Kerstin Valinder Strinnholm has more than 30 years’ experience in the Pharma industry, initially focussing on sales and marketing, more recently in strategic and business development. After some 15 years in AstraZeneca, responsible for Business Strategy & Licensing for the Gastro Intestinal Division, Kerstin switched to Nycomed in 1999 as EVP of Corporate Development. Nycomed’s growth strategy relied on acquisitions and in licensing of complementary technologies and products, hence Kerstin was instrumental to value building of the company. In 2011, Takeda incorporated Nycomed for $14bn. Kerstin is now heading her own consultancy business, focussing on pharmaceutical companies.
Research Interest
Haematology
